Erez Rechavi

671 citations
17 papers · 443 indexed · h-index 11
Topics
Immunodeficiency and Autoimmune Disorders (11 papers)Immune Cell Function and Interaction (7 papers)Blood disorders and treatments (5 papers)

In The Last Decade

Erez Rechavi

17 papers receiving 437 citations

Peers

Erez Rechavi
Comparison fields: 5 of 55
  • Immunology 319
  • Genetics 102
  • Pulmonary and Respiratory Medicine 84
  • Epidemiology 84
  • Molecular Biology 71
Replace Sandra de Bruin-Versteeg with:
Sandra de Bruin-Versteeg Netherlands
Mauro Giacomelli Italy
Jason Raasch United States
HyeMee Joo United States
Goh Murayama Japan
Ellen Schatorjé Netherlands
Kara B. Anthony United States
K Koss United Kingdom
Mukesh Desai India
Kathrin Pieper Germany
Erez Rechavi relative to Sandra de Bruin-Versteeg Netherlands Sandra de Bruin-Versteeg's profile →
Citations per field
00.5×7.8×
Sandra de Bruin-Versteeg · 1×
Citations per year

Countries citing papers authored by Erez Rechavi

Since Specialization
Citations

This map shows the geographic impact of Erez Rechavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erez Rechavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erez Rechavi more than expected).

Fields of papers citing papers by Erez Rechavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erez Rechavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erez Rechavi. The network helps show where Erez Rechavi may publish in the future.

Co-authorship network of co-authors of Erez Rechavi

This figure shows the co-authorship network connecting the top 25 collaborators of Erez Rechavi. A scholar is included among the top collaborators of Erez Rechavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erez Rechavi. Erez Rechavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 3
2 3
3 10
4 27
5 12
6 76
7 1
8 37
9 18
10 59
11 16
12 17
13 22
14 12
15 2
16 10
17 118

About Erez Rechavi

Erez Rechavi is a scholar working on Immunology, Genetics and Immunology and Allergy, having authored 17 papers that have together received 443 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (11 papers), Immune Cell Function and Interaction (7 papers) and Blood disorders and treatments (5 papers). The work is most often cited by research in Immunology (319 citations), Genetics (102 citations) and Genetics (36 citations). Erez Rechavi has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Raz Somech, Atar Lev, Anthony Simon, Yu Nee Lee, Yoav Yinon, Boaz Weisz, Luigi D. Notarangelo, Ninette Amariglio, Dror S. Shouval and Lael Werner. Their work appears in journals such as Developmental Cell, Science Translational Medicine and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026